Health Trials

Drug-refractory Paroxysmal Atrial Fibrillation

1

Review clinical trials related to Drug-refractory Paroxysmal Atrial Fibrillation. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

PulseMagic™ TrueForce™ PAF NMPA Study

This clinical investigation is intended to demonstrate safety and effectiveness of the PulseMagic™ TrueForce™ Ablation Catheter and the PulseMagic™Pulse Field Ablation (PFA) Generator, and Columbus™ 3D EP Navigation System with Pulsed Field Ablation Software for the treatment of symptomatic, recurrent, drug refractory paroxysmal atrial fibrillation (PAF).

Participants needed: 150
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Shanghai MicroPort EP MedTech Co., Ltd.Updated: Jul 22, 2026Locations: 1
Eligibility criteria

Aged ≥ 18 years old. [+4]

Patients with a history of atrial fibrillation ablation. [+9]

Read more